Detalles de la búsqueda
1.
The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis.
Liver Int
; 36(12): 1860-1866, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27439331
2.
Monotherapy with darunavir/ritonavir or lopinavir/ritonavir versus standard antiretroviral therapy: a randomized clinical trial (2pm Study).
New Microbiol
; 39(4): 290-294, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27551725
3.
Optimizing HIV therapy. A consensus project on differences between cytidine analogues and regime compactness.
New Microbiol
; 37(3): 285-306, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25180844
4.
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages.
Retrovirology
; 10: 154, 2013 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24330394
5.
Boosted or unboosted atazanavir as a simplification of lopinavir/ritonavir-containing regimens.
New Microbiol
; 36(3): 239-49, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23912865
6.
Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study.
Front Oncol
; 13: 1044098, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36761977
7.
JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.
J Cell Physiol
; 227(10): 3511-7, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22253012
8.
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.
New Microbiol
; 35(1): 17-25, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22378549
9.
Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals.
J Infect Dis
; 203(9): 1235-9, 2011 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21398398
10.
Therapeutic monitoring and variability of atazanavir in HIV-infected patients, with and without HCV coinfection, receiving boosted or unboosted regimens.
Ther Drug Monit
; 33(3): 303-8, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21544015
11.
Persistence of SARS-CoV-2 RNA in post-mortem swab 35 days after death: A case report.
Forensic Sci Int
; 319: 110653, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33360242
12.
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count.
Int J Infect Dis
; 104: 315-319, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33359064
13.
Enhancing care for people living with HIV: current and future monitoring approaches.
Expert Rev Anti Infect Ther
; 19(4): 443-456, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33054479
14.
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing?
Dig Liver Dis
; 53(4): 456-460, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32732070
15.
Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens.
J Med Virol
; 82(1): 116-22, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19950236
16.
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.
New Microbiol
; 33(3): 195-206, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20954437
17.
Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs.
Viruses
; 12(3)2020 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32106574
18.
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation.
HIV Res Clin Pract
; 21(1): 34-43, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32129161
19.
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study.
J Acquir Immune Defic Syndr
; 84(3): 290-294, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32101882
20.
JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy.
J Neurovirol
; 15(1): 51-6, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19043822